שולי רווח תפעולי Pacific Biosciences (PACB)

The actual operating margin of Pacific Biosciences (PACB) demonstrates business efficiency, where -98.10 reflects the baseline level of the metric. Pacific Biosciences (PACB) minimizes plastic waste and chemicals as part of its ESG initiatives. The issuer's stability remains high, although government grants may influence equipment procurement. The company is currently actively deploying Revio systems to reduce genome sequencing costs and optimize biochemistry.
פילוחים אנליטיים של חברת Pacific Biosciences

Operating margin measures the share of profit from core operations in total revenue before financial expenses and taxes. For Pacific Biosciences (PACB), this calculation reflects the scaling efficiency of Revio systems and the optimization of biochemistry costs. By analyzing the operating profit margin on GURU.Markets, an investor can see the real-time profitability dynamics of the R&D cycle. Growth in this metric confirms a reduction in sequencing costs, signaling the business's transition toward sustainable operational efficiency.